Patent · US Active

Method for enzymatic treatment of tissue products

US10207025B2 · kind B2 · utility

3Cited by
21References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2014
Grant dateFeb 19, 2019
Priority date
Expiry dateSep 5, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/40
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods for treating tissue matrices and tissue matrices produced according to the methods are provided. The methods can include treating a tissue matrix with a proteolytic enzyme to produce a desired pliability of the tissue matrix and/or to control the immunogenicity of the tissue matrix. The methods can also comprise performing an assay to determine if contacting the at least one collagen-containing tissue matrix with a proteolytic enzyme has altered the at least one collagen-containing tissue matrix to reduce a human immune response to the tissue matrix. The methods can comprise treatment with alcalase under conditions controlled to produce a desired pliability without unacceptable alteration in collagen structure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.